Patents by Inventor Kevin Gaston

Kevin Gaston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inducer of apoptosis
    Publication number: 20050014688
    Abstract: This invention relates to the use of a mutant E2 polypeptide to induce apoptosis (a form of programmed cell death) in cells. The mutant E2 derived polypeptide is p53 binding deficient. Preferably it is unable to bind p53; or able to bind p53 but unable to induce p53-dependent apoptosis.
    Type: Application
    Filed: July 23, 2002
    Publication date: January 20, 2005
    Inventor: Kevin Gaston
  • Cancer therapy
    Publication number: 20040102422
    Abstract: Use of a steroid hormone or steroid hormone analogue and at least a portion of HPV E2 protein in the preparation of a pharmaceutical composition for the treatment of cervical cancer.
    Type: Application
    Filed: October 31, 2002
    Publication date: May 27, 2004
    Applicant: The University of Bristol
    Inventor: Kevin Gaston